microsmallcap, Author at MicroSmallCap

CytoSorbents to Present at Two Upcoming Investor Conferences

PR Newswire MONMOUTH JUNCTION, N.J. , May 19, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces ... [Read]

Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting

May 19

– Nonclinical data demonstrate that a single intracochlear administration of an AAVAnc80 vector led to durable restoration of auditory function and was well tolerated, supporting planned clinical development of AK-OTOF for the treatment of OTOF ... [Read]

Atalaya Mining PLC Announces Q1 2022 Financial Results

May 19

Good Financial Performance Despite Impact of Energy Prices, Inflation and Transport Sector Strike NICOSIA, CYPRUS / ACCESSWIRE / May 19, 2022 / Mining Plc (AIM:ATYM); (TSX:AYM) is pleased to announce its unaudited quarterly results for ... [Read]

Magic Software (MGIC) Upgraded to Buy: Here’s What You Should Know

May 18

Magic Software (MGIC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates — one of the most powerful forces impacting ... [Read]

New Gold Completes Redemption Of Its Remaining Outstanding 6.375% Senior Notes

May 16

PR Newswire TORONTO , May 16, 2022 /PRNewswire/ – New Gold Inc. (“New Gold” or the “Company”) (TSX: NGD) (NYSE American: NGD) announces completion of the previously announced redemption of its outstanding $100 million aggregate ... [Read]

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

May 15

PR Newswire SAN DIEGO and SHANGHAI , May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug ... [Read]

Calliditas Therapeutics Launches an Online Patient Platform

May 14

This launch coincides with the inaugural IgAN Awareness Day STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) — Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the launch of IgAN Connect, a new ... [Read]

Articles by microsmallcap